首页> Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research> Using Data From Routine Care to Estimate the Effectiveness and Potential Limitations of Outcomes-Based Contracts for Diabetes Medications.

Using Data From Routine Care to Estimate the Effectiveness and Potential Limitations of Outcomes-Based Contracts for Diabetes Medications.

导出原文传递

翻译打印收藏纠错

第一作者： Michael,Fralick

第一单位： Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Sinai Health System, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: mike.fralick@mail.utoronto.ca.

作者： Michael,Fralick ^[1] ; Joshua J,Gagne ^[2] ; Elisabetta,Patorno ^[3] ; Raisa,Levin ^[3] ; Aaron S,Kesselheim ^[2]

作者单位： Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Sinai Health System, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: mike.fralick@mail.utoronto.ca. ^[1] Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. ^[2] Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. ^[3]

关键词 diabetes drug prices outcomes-based contracts